Page 1 of Clinical Trials for "Leukemia, Promyelocytic, Acute", 118 Total Matches
- 1RecruitingLast Updated: October 22, 2007Condition(s): Relapsed Acute Promyelocytic Leukemia; Refractory Acute Promyelocytic Leukemia
- 2RecruitingLast Updated: November 9, 2011Condition(s): Leukemia, Promyelocytic, Acute
- 3RecruitingLast Updated: July 8, 2011Condition(s): Leukemia, Promyelocytic, Acute
- 4CompletedLast Updated: January 11, 2008Condition(s): Leukemia, Promyelocytic, Acute
- 5RecruitingLast Updated: May 9, 2008Condition(s): Acute Promyelocytic Leukemia
- 6RecruitingLast Updated: August 16, 2007Condition(s): Acute Promyelocytic Leukemia
- 7RecruitingLast Updated: January 9, 2012Condition(s): Acute Promyelocytic Leukemia
- 8CompletedLast Updated: March 27, 2008Condition(s): Acute Promyelocytic Leukemia
- 9RecruitingLast Updated: January 9, 2012Condition(s): Acute Promyelocytic Leukemia
- 10TerminatedLast Updated: May 18, 2011Condition(s): Acute Promyelocytic Leukemia
- 11WithdrawnLast Updated: September 23, 2010Condition(s): Acute Promyelocytic Leukemia
- 12RecruitingLast Updated: September 15, 2011Condition(s): Acute Promyelocytic Leukemia; Relapse
- 13RecruitingLast Updated: January 20, 2012Condition(s): Acute Promyelocytic Leukemia
- 14CompletedLast Updated: August 5, 2010Condition(s): Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With T(15;17)(q22;q12); Adult Acute Myeloid Leukemia With T(16;16)(p13;q22); Adult Acute Myeloid Leukemia With T(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Acute Promyelocytic Leukemia (M3); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myeloid Leukemia in Remission; Childhood Acute Myelomonocytic Leukemia (M4); Childhood Acute Promyelocytic Leukemia (M3); Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; De Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
- 15Recruiting
- 16Active, not recruitingLast Updated: April 4, 2012Condition(s): Acute Promyelocytic Leukemia
- 17CompletedLast Updated: January 23, 2008Condition(s): Leukemia, Promyelocytic, Acute
- 18Active, not recruitingLast Updated: March 30, 2012Condition(s): Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic Syndromes
- 19RecruitingLast Updated: March 13, 2012Condition(s): Acute Promyelocytic Leukemia
- 20Active, not recruitingLast Updated: October 1, 2010Condition(s): Leukemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Leukemia%2C+Promyelocytic%2C+Acute%22
